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http://dx.doi.org/10.1016/j.stemcr.2016.08.009SUMMARYMesenchymal stem cells (MSCs) can donatemitochondria and rescue anthracycline-induced cardiomyocyte (CM) damage, although the
underlyingmechanisms remain elusive.We determined that the superior efficiency of mitochondrial transfer by human induced-plurip-
otent-stem-cell-derived MSCs (iPSC-MSCs) compared with bone marrow-derived MSCs (BM-MSCs) is due to high expression of intrinsic
Rho GTPase 1 (MIRO1). Further, due to a higher level of TNFaIP2 expression, iPSC-MSCs are more responsive to tumor necrosis factor
alpha (TNF-a)-induced tunneling nanotube (TNT) formation for mitochondrial transfer to CMs, which is regulated via the TNF-a/
NF-kB/TNFaIP2 signaling pathway. Inhibition of TNFaIP2 or MIRO1 in iPSC-MSCs reduced the efficiency of mitochondrial transfer
and decreased CMs protection. Compared with BM-MSCs, transplantation of iPSC-MSCs into a mouse model of anthracycline-induced
cardiomyopathy resulted in more human mitochondrial retention and bioenergetic preservation in heart tissue. Efficacious transfer of
mitochondria from iPSC-MSCs to CMs, due to higher MIRO1 expression and responsiveness to TNF-a-induced nanotube formation,
effectively attenuates anthracycline-induced CM damage.INTRODUCTION
Anthracycline antibiotics, including doxorubicin (Dox),
remain the cornerstone of treatment for a variety of malig-
nancies (Arcamone et al., 2000). Nonetheless, they are well
known to cause dose-dependent, progressive myocardial
damage known as anthracycline-induced cardiomyopathy
(AIC), which hinders their broad clinical application (Chen
et al., 2011). As more cancer patients survive, AIC has
become more prevalent and is now the leading cause of
morbidity and mortality among such patients. Although
there remains some controversy about the conflicting
beneficial (anticancer) and detrimental (cardiotoxic) effects
of anthracycline therapy, compelling evidence indicates
that different mechanisms are involved. Of note, anthracy-
cline antitumor efficacy is associated with nuclear DNA
intercalation topoisomerase II inhibition and drug-DNA
adduct formation (Capranico et al., 1989). Cardiotoxicity
is largely ascribed to oxidative stress and mitochondrial
damage (Lebrecht et al., 2005). Recent studies suggest
that inhibition of mitochondrial biogenesis is the main
pathology underlying AIC (Suliman et al., 2007) and is
separate from its antineoplastic activity of topoisomerase
II inhibition (Holm et al., 1989). Although angiotensin-Stem Cell Re
This is an open access article under the Cconverting enzyme inhibitors alone or with b-blockers
may limit the progression of AIC (Georgakopoulos et al.,
2010), the only curative therapy for those with severe heart
failure is heart transplantation (Lenneman et al., 2013).
Anthracycline-induced inflammation and mitochon-
drial damage can lead to disruption of the homeostasis of
endogenous myocardial regeneration by direct cardiomyo-
cyte (CM) death and depletion of resident cardiac progen-
itor cells (De Angelis et al., 2010). It has been shown that
transplantation of adult mesenchymal stem cells (MSCs)
protects CMs against AIC (Pinarli et al., 2013), but the un-
derlying mechanisms remain unclear. They may be related
to large variations in MSCs derived from different sources
(Xin et al., 2010). Compared with adult MSCs, single-cell
colony-derived MSC lines from human pluripotent stem
cells (PSCs) show the same phenotype as bone marrow
(BM)-MSCs and exhibit tissue repair (Lian et al., 2010)
and anti-inflammatory (Sun et al., 2015) actions. In addi-
tion, they have the advantage of less batch-to-batch varia-
tion and can be expanded to >120 population doublings
without obvious senescence (Lian et al., 2010). Apart
from the secretion of paracrine factors (Amsalem et al.,
2007), recent studies also report efficacious direct
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(iPSC-MSCs) to injured cells as another mechanism to pro-
tect against tissue injury (Islam et al., 2012; Li et al., 2014).
Based on these observations and the fact that iPSC-MSCs
display a much higher efficiency for mitochondria transfer
than adult BM-MSCs in response to inflammation, we
hypothesized that this higher mitochondrial transfer po-
tential may be associated with some intrinsic molecules
involved in mediating mitochondrial movement to the
native cells after transplantation. In this study, we have re-
vealed that functional mitochondrial transfer from human
iPSC-MSCs plays a critical role in cardio-protection
against Dox-induced mitochondrial damage. Importantly,
we demonstrated that the higher efficiency of mitochon-
drial transfer from human iPSC-MSCs is attributed to
high-level intrinsic expression of MIRO1, a mitochondrial
Rho GTPase 1 that can modulate intercellular mitochon-
drial movement along microtubules (Ahmad et al., 2014).
Moreover, iPSC-MSCs were more responsive than BM-
MSCs to pro-inflammatory cytokine tumor necrosis factor
alpha (TNF-a)-induced formation of tunneling nanotubes
(TNT) (Wang et al., 2011), through which mitochondria
were transported.RESULTS
Efficiency of Mitochondrial Transfer from iPSC-MSCs
to CMs in Response to Dox-Induced Injury
Wefirst examined themitochondrial transfer fromMSCs to
neonatal mice CMs (NMCs) under Dox challenge. Co-cul-
ture of Celltrace-labeled NMCs (violet) and MitoTracker-
labeled MSCs (green) revealed mitochondrial transfer
from MSCs to NMCs (Figures S1Ai–S1Aiv). In agreement
with previous studies (Ahmad et al., 2014; Vallabhaneni
et al., 2012), in the co-culture of NMCs and MSCs, we de-
tected only MitoTracker of MSCs in NMCs but no Celltrace
of NMCs in MSCs. Co-culture of human MSCs with NMCs
indicated that human mitochondrial COX-4 was detected
in NMCs that were positive for TROPONIN expression
(Figures S1Bv –S1Bvii). We further examined the mito-
chondrial transfer efficiency after 4, 12, 24, and 48 hr of
co-culture. Compared with BM-MSCs, more effective mito-
chondrial transfer from iPSC-MSCs to NMCs was detected
by fluorescence-activated cell sorting (FACS) after 24 and
48 hr co-culture (Figures 1Ai and 1Aii). Moreover, themito-
chondrial transfer ratio of MSCs to NMCs at 48 hr was
similar to that at 24 hr, indicating that 24 hr co-culture of
MSCs with NMCs achieved the peak efficiency of mito-
chondrial transfer with and without Dox challenge.
Notably, mitochondrial uptake was enhanced when
NMCs were exposed to Dox, suggesting that injured
NMCs increased the uptake of mitochondria from iPSC-
MSCs (Figure 1Aii). We also examined the mitochondrial750 Stem Cell Reports j Vol. 7 j 749–763 j October 11, 2016transfer efficiency from iPSC-MSCs to adult mice HL-1 or
human AC16 CMs. Compared with NMCs, no significant
difference in mitochondrial transfer ratio was observed
from iPSC-MSCs to either HL-1 or AC16 CMs (Figure S1C),
indicating that the efficiency of mitochondrial transfer
from MSCs to CMs is not determined by the stage of
CMs, but more likely the conditions to which they are
exposed.
To exclude the possibility of leakage ofMitoTracker green
dye taken up by NMCs frommedium, we transfected iPSC-
MSCs with a lentiviral-mediated mitochondrial-specific
fragment fused with GFP (LV-MITO-GFP), allowing us to
monitor mitochondrial trafficking. MITO-GFP-iPSC-MSCs
(Figure 1Bi) were co-cultured with NMCs for 24 hr
under Dox challenge. Immunostaining showed that
TROPONIN-positive NMCs were positive for MITO-GFP,
indicating that mitochondria had translocated from
MSCs to NMCs (Figures 1Bii–1Biv). We also co-cultured
unlabeled NMCs with pLL3.7-GFP lentivirus-labeled
iPSC-MSCs under Dox for 24 hr. Unlabeled NMCs were
separated from the co-culture. Isolated NMCs were sub-
jected to immunostaining for anti-TROPONIN and anti-
human mitochondrial COX-4. We observed the presence
of human COX-4 in NMCs, indicating that mitochondrial
transfer had occurred between iPSC-MSCs and NMCs
(Figures 1Ci–1Ciii).
Functional Mitochondrial Transfer by iPSC-MSCs
Protects against Dox-Induced CM Damage and Is
Independent of Paracrine Action of MSCs
We examined whether mitochondria transferred from
MSCs to NMCs are functional. Celltrace-labeled NMCs
and MITO-GFP-iPSC-MSCs were co-cultured for 24 hr
under Dox challenge. Cells were separated by cell sorting
(Figure 1Di). To verify the successful separation, immu-
nostaining showed that TROPONIN-positive cells were
co-localized with MITO-GFP in mitochondrial-transferred
NMCs (Figure 1Dii), and no MITO-GFP was detected in
non-mitochondrial-transferred NMCs (Figure 1Diii). To
determine the respiratory function of transferred mito-
chondria, the cellular oxygen consumption rate (OCR) of
NMCs with and without transferred mitochondria was
examined. The bioenergetics profiles of different groups
of NMCs are shown in Figure 1E. Four measurements
were made: (1) basal mitochondrial OCR measured in me-
dium containing 4.5 g/L glucose; (2) after inhibition of
ATP synthase with oligomycin (Olig) (1 mM), ATP synthesis
turnover and respiration driving proton leak were assessed
bymeasuringOCR; (3) after treatmentwith the uncoupling
agent carbonyl cyanide-p-trifluoromethoxyphenylhydra-
zone (FCCP) (2 mM), maximal mitochondrial respiratory
capacity was determined by OCR; and (4) non-mitochon-
drial respiration was assessed by measuring OCR after
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Figure 1. Distinct Mitochondria Transfer from iPSC-MSCs to NMCs Rescues Dox-Induced Mitochondrial Damage and Preserves
Cellular Bioenergetics
(A) (Ai) Representative distribution of Celltrace-labeled NMCs (violet) and MitoTracker-labeled MSCs (green) in co-cultured cells analyzed
by FACS. (Aii) Time course of the mitochondrial transfer ratio between MSCs and Dox-stressed NMCs distributed at Q2 phase and the
percentage of this population over the total NMCs are presented (*p < 0.01, iPSC-MSCs vs BM-MSCs; #p < 0.01, non-Dox stressed versus Dox
stressed).
(B) (Bi) iPSC-MSCs were transfected with lentiviral-MITO-GFP plasmid. (Bii, Biii, and Biv) MITO-GFP-MSCs were co-cultured with Celltrace-
labeled NMCs under Dox challenge for 24 hr. After sorting, immunostaining showed that MITO-GFP was present in NMCs, indicating transfer
of MITO-GFP from MSCs to NMCs (Biv).
(C) Co-culturing of NMCs with pLL3.7-GFP lentivirus-iPSC-MSCs for 24 hr, and sorting out GFP-negative NMCs. Immunostaining of
TROPONIN and human COX-4 in the NMCs revealed the presence of human mitochondria (Ci–Ciii).
(D) After co-culture, the mitochondrial-transferred and the non-mitochondrial-transferred NMCs were separated by FACS (Di). Repre-
sentative images illustrating MITO-GFP expression in mitochondrial-transferred NMCs (Dii) but not in non-mitochondrial-transferred NMCs
(Diii).
(E) OCR of NMCs from different groups was measured over time (minutes). The injection order of Olig, FCCP, and Rot are shown.
(F) Basal mitochondrial OCR (Fi), ATP production (Fii), and maximum respiration (Fiii) of NMCs from different groups was calculated
(*p < 0.01 versus control; #p < 0.01 versus Dox; yp < 0.01 versus non-mitochondrial transfer).
Data represent the means ± SD of three independent experiments.treatment with complex I inhibitor, rotenone (Rot) (2 mM).
Compared with control NMCs, basal mitochondrial OCR,
ATP production, and maximum respiration were signifi-
cantly decreased in the Dox-treated NMCs but greatlyrecovered in NMCs isolated after co-culture with iPSC-
MSCs (Figure 1F). Basal mitochondrial OCR, ATP produc-
tion, and maximum mitochondrial respiratory function
were markedly improved in NMCs with mitochondriaStem Cell Reports j Vol. 7 j 749–763 j October 11, 2016 751
transferred from MSCs compared with NMCs without
transferred mitochondria (Figure 1F).
We also tested the effect of mitochondrial transfer of
MSCs on the viability of NMCs exposed to Dox challenge
for 24 hr. Compared with control NMCs, Dox-induced
necrosis of NMCs was dramatically attenuated after co-cul-
ture with MSCs (Figures S2A and S2B). Notably, using the
same NMC and MSC co-culture system, after we separated
mitochondrial-transferred NMCs from non-mitochon-
drial-transferred NMCs, cell death was far less for NMCs
with transferred mitochondria, indicating that mitochon-
drial transfer from MSCs was protective against Dox, and
such protection was independent of the paracrine action
of iPSC-MSCs (Figures S2A and S2B). In addition, MSCs
were less sensitive than CMs to Dox-induced cell death:
1 mM Dox treatment notably damaged NMCs (Figures
S2A and S2B), whereas MSCs were not obviously affected
(Figure S2C).
To further clarify that functional improvement was
due to the transferred mitochondria, we compared the
mitochondrial respiratory function of NMCs with trans-
ferred mitochondria, purified from either native iPSC-
MSCs or Rot-treated iPSC-MSC co-culture. Rot has been
used to induce mitochondrial dysfunction (Ahmad
et al., 2014). Compared with control NMCs, mitochon-
drial OCR of NMCs was notably reduced after treatment
with 50 nM Rot for 2 hr, although viability of NMCs was
not affected (data not shown). Therefore, MITO-GFP-
iPSC-MSCs were treated with PBS or Rot for 2 hr and
then co-cultured with Celltrace-labeled NMCs for 24 hr
under Dox challenge. FACS analysis showed that the
efficiency of mitochondrial transfer from Rot-treated
and non-Rot-treated iPSC-MSCs to NMCs was similar
(data not shown). Next, NMCs with transferred mito-
chondria were isolated from iPSC-MSCs or Rot-treated
iPSC-MSCs, and OCR was measured. The bioenergetics
profile of different groups is shown in Figure 2A.
Compared with only Dox-treated NMCs, Dox-treated
NMCs isolated from co-culture with iPSC-MSCs or Rot-
treated iPSC-MSCs presented markedly higher levels
of basal mitochondrial OCR, ATP production, and
maximum mitochondrial respiratory function (Figures
2Bi–2Biii). Notably, compared with NMCs isolated from
Rot-treated MSCs, NMCs isolated from iPSC-MSCs further
showed a significantly higher level of basal mitochondrial
OCR, ATP production, and maximum respiratory mito-
chondrial function, highlighting that only functional
mitochondrial transfer could strongly protect NMCs.
Those MSCs with impaired mitochondria (i.e., aged
MSCs) may not be acceptable therapeutic donors. We
also examined cytokines secreted by iPSC-MSCs and Rot-
treated iPSC-MSCs with or without TNF-a stimulation.
There was no significant difference between MSCs and752 Stem Cell Reports j Vol. 7 j 749–763 j October 11, 2016Rot-treated MSCs in the secretion of monocyte chemo-
tactic protein-1 (MCP-1), interleukin-6 (IL-6), and inter-
leukin-8 (IL-8), or vascular endothelial growth factor
(VEGF), both in basal conditions and when stimulated
by TNF-a (Figures 2Ci–2Civ), suggesting that the func-
tional protection afforded to NMCs by mitochondrial
transfer is separate to the above paracrine effect.
iPSC-MSCs with High Potency of Mitochondrial
Transfer Have High Expression of Intrinsic MIRO1
To explore the molecular basis of the higher efficiency of
mitochondrial transfer by PSC-derived MSCs compared
with BM-MSCs, we reviewed our previous microarray data
(Lian et al., 2007, 2010). Pairwise comparison of gene
expression between human embryonic stem cell (hESC)/
iPSC-MSCs and BM-MSCs revealed a correlation coefficient
of 0.72 (Lian et al., 2007), suggesting significant conserva-
tion of gene expression in both hESC-MSCs and BM-MSCs,
albeit with a fewdifferences. A search for the distinguishing
expression level of mitochondrial motor-protein-related
genes among hESC-MSCs, iPSC-MSCs, and BM-MSCs,
revealed that MIRO1, an integral protein involved in
mitochondrial transportation (Ahmad et al., 2014), is high-
ly expressed by human iPSC-MSCs and hESC-MSCs but
not BM-MSCs. Western blot confirmed that the protein
level of MIRO1 is truly overpresented in human iPSC-
MSCs and hESC-MSCs compared with BM-MSCs (Figures
3Ai and 3Aii).
To determine whether a high level of MIRO1 is a real key
driver for the high level of intercellular mitochondrial
transfer in iPSC-MSCs, we performed a loss- and gain-of
function experiment by knockdown of MIRO1 with short
hairpin RNA (shRNA) and replenishment by overexpres-
sion of MIRO1. Accordingly, MITO-GFP-iPSC-MSCs were
introduced with scramble control shRNA (iPSC-MSCs-
MIRO1Sc), MIRO1-shRNA (iPSC-MSCs-MIRO1Lo) and over-
expressed MIRO1 (iPSC-MSCs-MIRO1Hi), respectively, and
co-cultured with Celltrace-labeled NMCs at 1:1 ratio under
Dox challenge. After 48 hr, themitochondrial transfer ratio
of MSCs to NMCs was measured by FACS. Compared
with scramble shRNA-treated iPSC-MSCs (iPSC-MSCs-
MIRO1Sc), the protein level of MIRO1 was remarkably
decreased in iPSC-MSCs-MIRO1Lo and was accompanied
by a significant reduction in mitochondrial donation (Fig-
ures 3Bi–3Biii). Conversely, overexpression of MIRO1 in
iPSC-MSCs-MIRO1Hi resulted in a striking increase in
mitochondrial donation (Figures 3Bi–3Biii). Similarly, co-
culture of BM-MSCs of overexpressed MIRO1 with NMCs
under Dox challenge also led to an enhanced mitochon-
drial transfer efficiency compared with native BM-MSCs
(Figures S3A and S3B). These results indicate that MIRO1
is a key molecule governing intercellular mitochondrial
movement in iPSC-MSCs. On the contrary, when MIRO1
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Figure 2. Mitochondrial Transfer from iPSC-MSCs Rescues Dox Insult and Is Independent of Paracrine Effects
(A) OCR of NMCs sorted from Rot-treated iPSC-MSCs or iPSC-MSCs was measured over time (minutes).
(B) Basal mitochondrial OCR (Bi), ATP production (Bii), and maximum respiration (Biii) of NMCs from different groups was calculated.
(C) Quantification of paracrine products including MCP-1 (Ci), IL-6 (Cii), IL-8 (Ciii), and VEGF (Civ) secreted by iPSC-MSCs with or without
Rot treatment after TNF-a stimulation.
Data represent the means ± SD of three independent experiments. *p < 0.01 versus control; #p < 0.01 versus Dox; yp < 0.01 versus
Rot-treated mitochondrial transfer. NS, not significant.was overexpressed in NMCs that were then co-cultured
with iPSC-MSCs under Dox challenge, the high level of
MIRO1 in NMCs had no impact on the mitochondrial
transfer from MSCs to NMCs (Figures S3C and S3D). To
verify that MITO-GFP translocation indicates real mito-
chondrial transfer, MITO-GFP positive and negative
NMCs were separated. GFP andmitochondrial-component
human COX-4 protein were detected in the MITO-GFP+-
NMC subpopulation, suggesting that MITO-GFP is a
reliable reporter of mitochondrial transfer from MSCs to
NMCs (Figures 3Ci–3Ciii). Compared with the NMCs
exposed to iPSC-MSCs-MIRO1Sc, inhibition of MIRO1
(iPSC-MSCs-MIRO1Lo) resulted in reduced abundance of
MITO-GFP and human COX-4 in the MITO-GFP+-NMCs.
Overexpression ofMIRO1 (iPSC-MSCs-MIRO1Hi) increasedthe abundance of MITO-GFP and human Cox4 content in
MITO-GFP+-NMCs (Figures 3Ci–3Ciii).
Formation of TNT between iPSC-MSCs and CMs for
Mitochondrial Transfer
It has been reported that F-actin-modulated formation of
TNT is a viable mechanism for mitochondrial transfer be-
tween adult stem cells and somatic cells and rescues their
respiration (Spees et al., 2006; Vallabhaneni et al., 2012).
We examined in vitro the role of TNT in the regulation of
iPSC-MSC mitochondrial transfer. MITO-GFP-iPSC-MSCs
were co-cultured with Celltrace-labeled NMCs under Dox
challenge. After 24 hr, stainingwith rhodamine phalloidin,
a high-affinity F-actin probe, showed that NMCs and iPSC-
MSCs were bridged by TNT, which allowed effectiveStem Cell Reports j Vol. 7 j 749–763 j October 11, 2016 753
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Figure 3. High Expression of Intrinsic MIRO1 by iPSC-MSCs Contributes to Mitochondrial Transfer
(A) The expression of MIRO1 by different types of iPSC-MSCs/ESC-MSCs was detected (Ai and Aii).
(B) (Bi) MIRO1 was measured in iPSC-MSCs transfected with scramble control shRNA (iPSC-MSCs-MIRO1Sc), MIRO1-shRNA (iPSC-MSCs-
MIRO1Lo), or MIRO1 cDNA plasmid (iPSC-MSCs-MIRO1Hi). (Bii) The expression of MIRO1 among different groups was evaluated. (Biii)
Mitochondrial transfer ratios between GFP-labeled (green) iPSC-MSCs-MIRO1Sc, iPSC-MSCs-MIRO1Lo, or iPSC-MSCs-MIRO1Hi and stressed
Celltrace-labeled NMCs (violet) were measured by FACS. We gated out violet+ NMCs and separated them into a violet+/GFP + population
with mitochondria transfer (MITO-GFP+-NMCs) and a violet+/GFP population without mitochondria transfer (MITO-GFP-NMCs) to
calculate the transfer ratio (violet+/GFP+ cells divided by the total violet+ cells).
(C) (Ci) Western blot analysis for expression of GFP and human COX-4 in the mitochondrial-transferred NMCs that were isolated after co-
culture with iPSC-MSCs-MIRO1Sc, iPSC-MSCs-MIRO1Lo, or iPSC-MSCs-MIRO1Hi. The expression of GFP (Cii) and human COX-4 (Ciii) among the
different groups was evaluated.
Data represent the means ± SD of three independent experiments. *p < 0.01.transfer of iPSC-MSC mitochondria to injured NMCs (Fig-
ures 4Ai–4Aiv), suggesting that TNTare vital for mitochon-
drial transfer. These findings were further confirmed by
time-lapse filming, which enabled us to monitor mito-
chondrial movement via TNT between iPSC-MSCs and
NMCs (Movies S1 and S2). We also examined TNT forma-
tion betweenMSCs andheathyNMCs: few TNT formations
between MSCs and healthy NMCs were observed
compared with MSCs and injured NMCs (data not shown).
To determine whether NMCs could take up leaked MSC
mitochondria from media without cell-cell connection,
we treated cells with cytochalasin B (Figure 4B), which
causes F-actin aggregation and retards TNT formation by
inhibiting actin polymerization and philiopodia elonga-754 Stem Cell Reports j Vol. 7 j 749–763 j October 11, 2016tion without affecting endocytosis (Abounit and Zurzolo,
2012; Cho et al., 2012). Administration of cytochalasin B
(350 nM) did not affect MSC viability (data not shown)
but almost no TNT formation by iPSC-MSCs was observed
(Figure 4Biii). Little mitochondrial transfer fromMSCs was
detected when NMCs were exposed to Dox (Figure 4Biv),
and the viability of NMCs was reduced, suggesting that
cell-cell contact, such as TNT, is essential for intercellular
mitochondrial transfer and to protect NMCs against
Dox-induced damage. As expected, the FACS result showed
that cytochalasin B treatment significantly reduced mito-
chondrial transfer from iPSC-MSCs to NMCs (Figure 4C).
To explore whether the mitochondrial transfer is uni- or
bidirectional, we co-cultured MITO-GFP-NMCs with
AB
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Figure 4. Effective Mitochondrial Transfer from iPSC-MSCs to Rejuvenate NMCs Is Mediated by TNT
(A) Representative images showing TNT formation and mitochondrial transfer between iPSC-MSCs and NMCs. (Ai) MITO-GFP labeling. (Aii)
Celltrace labeling. (Aiii) Phalloidin staining showing TNT formation between NMCs and iPSC-MSCs. (Aiv) Representative images of
mitochondrial transfer from MSCs to NMCs via TNT. Green arrows show that some MITO-GFP mitochondria were in the middle of the TNT.
(B) Representative image showing that TNT formation and mitochondrial transfer between NMCs and iPSC-MSCs were partially inhibited by
pre-treatment of MSCs with cytochalasin B. (Bi) MITO-GFP labeling. (Bii) Celltrace labeling. (Biii) Phalloidin staining showing inhibition of
TNT formation between NMCs and iPSC-MSCs. (Biv) Image illustrating the abolition of mitochondrial transfer from MSCs to NMCs.
(C) Mitochondrial transfer ratio between iPSC-MSCs and NMCs under cytochalasin B was analyzed by FACS.
Data represent the means ± SD of three independent experiments. *p < 0.01.Celltrace-labeled iPSC-MSCs for 24 hr under Dox chal-
lenge. Some MITO-GFP that originated from NMCs was
detected in iPSC-MSCs although the level of MITO-GFP
in iPSC-MSCs was much lower than in NMCs, suggesting
that mitochondrial transfer is bidirectional, not unidirec-
tional (Figure S4).
Responsiveness of iPSC-MSCs to TNF-a-Induced
Nanotube Formation Is Regulated via the TNF-a/
NF-kB/TNFaIP2 Signaling Pathway
Stress conditions or TNF-a can stimulate the formation of
TNTs between MSCs (Ahmad et al., 2014; Wang et al.,
2011). TNF-a was dramatically increased in mice with
AIC (Figure S7Diii) and when NMCs were exposed to Dox
challenge (from 360 ± 40 pg/mL to 5,880 ± 380 pg/mL,
p < 0.01). TNT formation was increased when MSCs wereexposed to TNF-a (20 ng/mL) (Figure 5Ai). PCR analysis
showed that TNF-a-treated MSCs displayed a significantly
increased expression of TNFaIP2, a TNF-a-induced protein
that regulates TNT formation (Figure 5Aii) (Ahmad et al.,
2014; Hase et al., 2009). In addition, compared with BM-
MSCs, expression of TNFaIP2 was markedly higher in
iPSC-MSCs responsive to TNF-a and was accompanied by
a significant increase in TNTnumbers per cell (Figure 5Aiii).
Nonetheless TNF-a-potentiated TNT formation was largely
diminished by small interfering RNA (siRNA)-mediated
knockdown of TNFaIP2 in both BM-MSCs and iPSC-
MSCs (Figures 5Ai–5Aiii), indicating that TNFaIP2 is a
downstream protein of TNF-a in the modulation of TNT
formation. Depletion of TNF-a from iPSC-MSC medium
by TNF-a antibody strikingly decreased the elevated expres-
sion of TNFaIP2 (Figure 5Bi). Similarly, TNF-a-augmentedStem Cell Reports j Vol. 7 j 749–763 j October 11, 2016 755
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TNT formation was largely decreased when TNF-a was
depleted with TNF-a antibody in iPSC-MSC culture
(Figure 5Bii).
We co-cultured the TNFaIP2siRNA-treated iPSC-MSCs
with NMCs and found TNT formation and mitochondrial
transfer were abrogated in the TNFaIP2siRNA-treated
group (Figures 5Ci and 5Cii). Likewise, FACS analysis
showed that after 24 hr co-culture of NMCs with control
siRNA or TNFaIP2siRNA-treated iPSC-MSCs under Dox
challenge, the mitochondrial transfer ratio in the iPSC-
MSCs-TNFaIP2si groupwas significantly reduced compared
with the iPSC-MSCs-consi group (Figure 5Ciii). In contrast,
compared with native BM-MSCs, TNT formation and the
mitochondrial transfer ratio were significantly increased
when BM-MSCs were overexpressed with TNFaIP2 under
Dox challenge (Figures S5A–S5C). Further, the mitochon-
drial transfer ratio in the BM-MSCs-TNFaIP2si group was
significantly reduced compared with the BM-MSCs-consi
group (Figure S5D).
To determine whether TNFaIP2-induced TNT formation
is mediated by the NF-kB pathway, we examined the
phosphorylated level of NF-kB subunit P65 (P-P65) and
TNT formation in iPSC-MSCs. TNF-a treatment enhanced
TNT formation (Figures 5Di and 5Dii), while the level of
P-P65 and TNFaIP2 was also significantly increased (Fig-
ure 5Diii). In contrast, treatment with NF-kB inhibitor
SC-514 (1 mM) significantly attenuated the level of P-P65
and TNFaIP2, and abolished TNF-a-induced TNT forma-
tion (Figures 5Di and 5Dii), suggesting that the TNF-a/
NF-kB/TNFaIP2 signaling pathway is predominantly
involved in TNF-a-mediated TNT formation by MSCs.
We also measured the expression of NF-kB and TNFaIP2
in the iPSC-MSCs-MIRO1si and iPSC-MSCs-MIRO1Hi.
The expression level of NF-kB activity and TNFaIP2 in
both iPSC-MSCs-MIRO1si and iPSC-MSCs-MIRO1Hi was
similar to the control iPSC-MSCs, indicating no directFigure 5. TNF-a Mediates TNT Formation by MSCs through the N
MSCs to NMCs
(A) (Ai) TNT formation was mediated by TNF-a stimulation and abroga
that TNFaIP2 was significantly increased with TNF-a stimulation and r
in the iPSC-MSC and BM-MSC groups when exposed to TNF-a or TNFaI
(B) (Bi) The elevated TNFaIP2 expression induced by TNF-a was stri
iPSC-MSC culture medium by immunoprecipitation with antibody TNF-a
TNF-a was neutralized by TNF-a antibody in iPSC-MSCs.
(C) Representative images showing TNT formation and mitochondria
chondrial transfer were partially abrogated by iPSC-MSCs with TNFaI
MITO-GFP-iPSC-MSCs-TNFaIP2si group. (Ciii) Mitochondrial transfer ra
MSCs and NMCs was analyzed by FACS.
(D) (Di) Representative images showing TNT formation by iPSC-MSCs in
of one cell in iPSC-MSCs when exposed to TNF-a or TNF-a + SC-514 int
NF-kB, and P65 NF-kB in the different groups.
Data represent the means ± SD of three independent experiments. *prelationship between MIRO1 and NF-kB/TNFaIP2 (data
not shown).
Transplantation of iPSC-MSCs but Not TNFaIP2si-
Treated iPSC-MSCs Effectively Protects against Dox-
Induced Cardiomyopathy
The experimental protocol is outlined in Figure 6A. Heart
function was evaluated by echocardiogram and pressure-
volume loop study (Figures 6B and 6C). At week 0, adminis-
tration of Dox significantly decreased the left ventricular
(LV) ejection fraction (LVEF) and fractional shortening (FS)
compared with the control group, indicating successful
establishment of an animal model of Dox-induced cardio-
myopathy (Figures 6Bi and 6Bii). At 3 weeks after cell trans-
plantation, LVEF, FS, LV +dp/dt, and LV systolic pressure
(LVSP) were significantly improved in theMSC transplanta-
tion group compared with the Dox group (Figure 6C). The
LVEF, FS, +dp/dt, and LVSP were also significantly higher
in the iPSC-MSC group compared with the iPSC-MSCs-
TNFaIP2si and BM-MSC groups (Figure 6C). Moreover, LV
internal diameter end diastole (LVIDd) was greatly reduced
andLVposteriorwall enddiastole (LVPWd)was significantly
increased in theMSC transplantation group compared with
the Dox group (Figures S6A and S6B). Notably, there were
significant differences in LVIDd and LVPWd in the iPSC-
MSCs group compared with iPSC-MSCs-TNFaIP2si and
BM-MSCs groups (Figures S6A and S6B).
Histological analysis revealed typical features of Dox-in-
duced cardiotoxicity, including a dilated LV chamber,
extensive CMdeath, myofibrillar degeneration, and vacuo-
lization (Figures 6Di–6Dx). MSC transplantation signifi-
cantly attenuated LV dilatation and myocardial damage
induced by Dox (Figures 6Di–6Dx). Sirius red staining
demonstrated a significantly increased extent of myocar-
dial fibrosis in the Dox group compared with control group
(Figures 6Dxi–6Dxv and 6E). Nonetheless, 3 weeks after cellF-kB Pathway and Contributes to Mitochondrial Transfer from
ted by TNFaIP2siRNA in iPSC-MSCs and BM-MSCs. (Aii) PCR showing
educed by TNFaIP2siRNA intervention. (Aiii) TNT number of one cell
P2siRNA intervention was calculated.
kingly decreased in iPSC-MSCs when TNF-a was depleted from the
. (Bii) TNF-a-augmented TNT formation was largely decreased when
l transfer between NMCs and iPSC-MSCs. TNT formation and mito-
P2 siRNA intervention. (Ci) MITO-GFP-iPSC-MSCs-consi group. (Cii)
tio between control siRNA-treated or TNFaIP2 siRNA-treated iPSC-
control, TNF-a, SC-154, or TNF-a + SC-154 group. (Dii) TNT number
ervention. (Diii) Western blot showing the level of TNFaIP2, P-P65
< 0.01.
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Figure 6. iPSC-MSC Transplantation Attenuates Dox-Induced Cardiomyopathy in Mice
(A) Schematic chart showing the introduction of Dox-induced cardiomyopathy and transplantation of BM-MSCs, iPSC-MSCs, or iPSC-MSCs-
TNFaIP2si.
(B) Heart function, including LVEF and FS, was measured at 0 weeks in control and Dox-treated mice (n = 6 mice per group). Data represent
the means ± SD. *p < 0.01.
(C) Effects of BM-MSCs, iPSC-MSCs, and iPSC-MSCs-TNFaIP2si on LVEF, FS, and LVSP were assessed at 3 weeks after cell injection (n = 6 mice
per group).
(D) At 3 weeks after cell transplantation, histological examination with H&E staining of heart tissue in different groups (Di–Dx). Compared
with control mice, a dilated LV cavity and thinner LV walls were observed in Dox-treated mice. Histological sections of heart tissue
displayed a different density of cardiomyocyte death, myofibrillar degeneration, and extensive vacuolization among experimental groups
(Dvi–Dx). Sirius red staining showed a different degree of myocardium fibrosis among the different experimental groups (Dxi–Dxv).
(E) Quantitative measurement of heart fibrosis in different experimental groups (n = 6 mice per group).
Data represent the means ± SD. *p < 0.01 versus control; #p < 0.01 versus Dox; yp < 0.01 versus BM-MSCs; $p < 0.01 versus iPSC-MSCs-
TNFaIP2si.transplantation, myocardial fibrosis was significantly
reduced compared with the Dox group (Figure 6E).
Notably, the extent of myocardial fibrosis in iPSC-MSC-
treated mice displayed the most prominent reduction
compared with the BM-MSC- or iPSC-MSCs-TNFaIP2si-
treated group (Figure 6E), suggesting that iPSC-MSCs are
superior to BM-MSCs and iPSC-MSCs-TNFaIP2si in attenu-
ation of Dox-induced myocardial fibrosis.758 Stem Cell Reports j Vol. 7 j 749–763 j October 11, 2016iPSC-MSC Attenuated Dox-Induced Cardiomyopathy
Is Accompanied by Augmented Mitochondrial
Retention and Bioenergetic Reservation
Dox-induced cell apoptosis over the myocardium was
largely alleviated after MSC treatment (Figures 7A and
7B). The reduced apoptosis in the iPSC-MSC group was
the most distinguished compared with the BM-MSC or
iPSC-MSCs-TNFaIP2si group (Figure 7B). When we
A B
C D
E
F
Figure 7. iPSC-MSC Transplantation Ameliorates Dox-Induced Cardiomyopathy and Is Linked to High Mitochondrial Donation and
Reserve Mitochondria Functions
(A) At 3 weeks after cell transplantation, apoptosis among the different groups was examined by TUNEL.
(B) Quantitative measurement of the apoptotic rate of the myocardium was expressed as a percentage of positive TUNEL cells versus total
DAPI-positive cells per viewing area (n = 6 mice per group).
(C) At 3 weeks after cell transplantation, immunostaining of human COX-4, TROPONIN, and HNA in heart tissue from different experimental
groups: BM-MSCs (Ci–Civ), iPSC-MSCs (Civ–Cviii), and iPSC-MSCs-TNFaIP2si (Cix–Cxii).
(D) Mouse heart tissue with human COX-4-positive region was removed by microdissection under a microscope. PCR for human DNA repeat
sequences ALU-SX (1), human specific mtDNA (2), mouse DNA repeat sequences C-mos (3), and mouse specific mtDNA (4).
(E) Quantitative measurement of COX-4-positive cells of the heart in BM-MSC-, iPSC-MSC-, and iPSC-MSC-TNFaIP2si-treated groups (n = 6
mice per group). Data represent the means ± SD. *p < 0.01.
(F) ATP of heart tissue from different groups. ATP content was expressed as fold change, normalized to the control group (n = 6 mice per
group).
Data represent the means ± SD. *p < 0.01 versus control; #p < 0.01 versus Dox; yp < 0.01 versus BM-MSCs; $p < 0.01 versus iPSC-MSCs-
TNFaIP2si.examined human mitochondria in heart tissue harvested
3 weeks after cell transplantation, abundant human mito-
chondrial protein COX-4 but not human nuclei antigen
(HNA) was evident in the mouse TROPONIN-positive
CMs, indicating that only human mitochondria from
transplanted MSCs were retained in mouse CMs (Figures
7Ci–7Cxii). Mice heart tissue with human COX-4-positive
region was isolated by microdissection microscopy. PCR
results for human DNA repeat sequences ALU-SX, mouse
DNA repeat sequences C-mos (Lian et al., 2010), human
specific mtDNA, and mouse specific mtDNA (Sokolova et al.,2004) indicated the presence of human mitochondrial
genome but no human nuclear genome in the heart tissue
(Figure 7D), in agreement with previous studies showing
that direct mitochondrial transfer of MSCs plays a key
role in tissue repair (Ahmad et al., 2014; Islam et al.,
2012; Li et al., 2014). Further, compared with BM-
MSC-treated mice, iPSC-MSC-treated mice exhibited far
more human COX-4-positive CMs (Figure 7E), suggesting
more mitochondria of iPSC-MSCs remained in CMs.
Nonetheless, the level of human mitochondrial COX-4
protein in mouse hearts was largely reduced in theStem Cell Reports j Vol. 7 j 749–763 j October 11, 2016 759
iPSC-MSCs-TNFaIP2si-treated mice compared with native
iPSC-MSC-treated mice (Figure 7E), in line with in vitro
evidence that inhibition of TNFaIP2 attenuated TNF-
a-stimulated mitochondrial transfer of iPSC-MSCs.
In addition, Dox-induced reduction of ATP inheart tissue
was notably reversed by MSC treatment (Figure 7F). The
level of ATP was markedly increased 1.49-fold with iPSC-
MSC treatment compared with BM-MSC treatment,
whereas this elevation in iPSC-MSCs was markedly
abrogated with iPSC-MSCs-TNFaIP2si treatment, suggest-
ing that TNFaIP2siRNA-pretreated iPSC-MSCs significantly
lose their capacity to rescue Dox-induced mitochondrial
damage (Figure 7F).
Increased oxidative stress and excessive inflammation
have been considered major mechanisms of Dox-induced
cardiomyopathy (Takemura and Fujiwara, 2007). We
therefore evaluated the density of dihydroethidium
(DHE), 3-nitrotyrosine (3-NT), and malonyldialdehyde
(MDA), surrogate markers of oxidative stress. This showed
that Dox-increased DHE (Figures S7Ai–S7Avi), 3-NT (Fig-
ures S7Bvii–S7Bxii), and MDA (Figure S7Ai) were markedly
abrogated by MSC treatment (Figures S7Bvii–S7Bxii), and
most prominent in the iPSC-MSC group compared with
the BM-MSC and iPSC-MSCs-TNFaIP2si groups (Figures
S7Avi and S7Bxii). Compared with control mice, Dox-in-
duced mice display severe inflammation as demonstrated
by markedly increased accumulation of CD45-positive
inflammatory cells (Figures S7Cxiii–S7Cxviii), and, con-
currently, elevated levels of pro-inflammatory cytokines
MCP-1 and TNF-a in heart tissues (Figures S7Dii and
S7Diii). In contrast, MSC transplantation significantly
decreased accumulation of CD45-positive cells (Fig-
ure S7Cxviii), and reduced the concentration of MCP-1
and TNF-a (Figures S7Dii and S7Diii). Notably, the magni-
tude of the reduction in CD45-positive cells and the
concentration of MCP-1 and TNF-a was most prominent
in the iPSC-MSC-treated group compared with the BM-
MSC or iPSC-MSCs-TNFaIP2si group (Figure S7D).DISCUSSION
Several reports have shown that BM-MSCs can transfer
mitochondria to other cells under various conditions
(Cho et al., 2012; Jackson et al., 2016; Spees et al., 2006).
Recent results also demonstrate that mitochondrial trans-
fer is an important mechanism of MSC therapy in tissue
regeneration (Islam et al., 2012) and repair (Li et al.,
2014). The mechanisms of mitochondrial transfer from
iPSC-MSCs remain elusive. It has been reported that
MIRO1 plays a critical role in the regulation of intercellular
mitochondrial transport from MSCs to airway epithelial
cells, leading to increased application of MSC-based ther-760 Stem Cell Reports j Vol. 7 j 749–763 j October 11, 2016apy (Ahmad et al., 2014). Our study extends these observa-
tions: higher intrinsic MIRO1 in iPSC-MSCs compared
with BM-MSCs contributed to higher mitochondrial trans-
fer to NMCs than BM-MSCs. Indeed, inhibition of MIRO1
by shRNA reduced the efficiency of mitochondrial transfer
by iPSC-MSCs, whereas overexpression ofMIRO1 increased
the efficiency.
Emerging evidence suggests that paracrine factor
profiling of MSCs is highly dependent on the microenvi-
ronment (Gao et al., 2016). Paracrine factors of iPSC-
MSCs are reported to effectively rescue Dox-induced CM
damage (Zhang et al., 2015). Nevertheless, how the thera-
peutic efficacy of MSCs is increased in an inflammatory
environment has not been well elucidated. Our results
revealed crosstalk between the pro-inflammatory microen-
vironment and the provoked efficiency of mitochondrial
transfer from MSCs. Importantly, functional mitochon-
drial transfer from iPSC-MSCs directly protects CMs against
Dox-induced damage. The protection of mitochondrial
transfer is separate to the paracrine actions of iPSC-MSCs
because CMs without mitochondrial transfer in the same
iPSC-MSC co-culture displayed poorer recovery of respira-
tory dysfunction. Alternatively, when co-culturing iPSC-
MSCs and CMs, non-mitochondrial-transferred CMs also
exhibited strong resistance to Dox-induced damage, sug-
gesting an important paracrine role of iPSC-MSCs (Zhang
et al., 2015). Paracrine action and mitochondrial transfer
are two independent but interactive actions that afford
MSC-mediated CMs protection against Dox insults. We
determined that mitochondrial transfer of iPSC-MSCs can
act as a ‘‘Trojan horse’’ through TNF-a induced formation
of TNT in vitro. Although the mechanisms remain elusive,
a higher level of TNFaIP2 detected in iPSC-MSCs may be
responsible for enhanced TNT formation (Hase et al.,
2009). We also discovered that a TNF-a/NF-kB/TNFaIP2
signaling pathway is predominantly involved in TNT
development for MSC-mediated mitochondrial transfer,
indicating that inflammation status may be a critical factor
to increase the efficiency of mitochondrial transfer of
MSCs, thus enhancing MSC-based therapeutic efficiency.
TNF-a activates the NF-kB pathway, which subsequently
stimulates TNFaIP2 expression (Chen et al., 2014).
Increased TNFaIP2 triggers F-actin polymerization, which
may subsequently upregulate TNT formation through
actin-driven protrusions of the cytoplasmic membrane in
MSCs (Hase et al., 2009; Wang et al., 2011). This contrib-
utes to mitochondrial donation from MSCs to NMCs.
The mechanism of the high level of MIRO1 presented in
iPSC/ECS-MSCs remains unknown. It has been proposed
that compared with the pluripotent stage, during embry-
onic development, fetal growth, or lineage differentiation
of PSCs, increased dynamic mitochondria biogenesis and
mobility are needed to meet metabolic shifts for organ
development (Teslaa and Teitell, 2015; Zhang et al., 2011).
Indeed, in our databases, we also found that not only
MIRO1 but also othermolecules involved inmitochondrial
network fusion (MFN1 and MFN2) and optic atrophy 1
(OPA1), and mitochondrial mobility MIRO2 and Kif5b,
were highly enriched in hESC/iPSC-derived MSC lines.
What senses and instructs mitochondrial mass enrichment
in lineage-specific MSCs and what other factors facilitate
intercellular mitochondrial movement are subjects for
future investigation. Whether other mitochondrial motor
proteins contribute to intercellular mitochondrial transfer
of iPSC-MSCs requires further study. Our results showed
that a higher level of intrinsic MIRO1 as well as superior
sensitivity to TNF-a-induced TNT formation contribute to
the higher mitochondrial transfer potency in iPSC-MSCs.
Our study reveals the protective effects of iPSC-MSCs
against AIC by efficacious mitochondrial transfer from
iPSC-MSCs to injured CMs, independently of MSC para-
crine effects, and that augmentationofDox-induced cardio-
myopathy with iPSC-MSCs is attributed to an intrinsically
high level of MIRO1 and high sensitivity to TNF-a-induced
TNT formation. Our study raises the possibility that modu-
latingmitochondrial transfer byMSCsmight be an effective
treatment of mitochondrial disorders including AIC.
This study has several limitations. First, our observations
are based solely on in vitro and in vivo rodent models. The
pathophysiological relevance of our findings should be
confirmed in humanoid large animals and clinical studies.
Second, although our data demonstrated the obligatory
role of MIRO1 and TNT formation in mediating the effi-
ciency of mitochondrial transfer from iPSC-MSCs via
TNF-a/NF-kB signaling, the signaling pathways that link
other mitochondrial motor proteins involved in intercel-
lular mitochondrial donation need further investigation.
Third, although we and others have observed no terato-
genic effects of iPSC-MSCs in animal studies (Table S1)
(Gruenloh et al., 2011; Lian et al., 2010), the genomic sta-
bility of iPSCs needs to be evaluated carefully before their
use is translated into clinical practice (Lister et al., 2011).
Fourth, the potential role of connexin-43-formed gap junc-
tions (Islam et al., 2012) ormicrovesicle secretion (Phinney
et al., 2015) in mitochondrial transfer has not been investi-
gated in this study.EXPERIMENTAL PROCEDURE
Cell Culture
Characterized BM-MSCs from healthy adults were commercially
acquired from Cambrex BioScience (catalog no. PT-2501). Human
iPSC-MSCs derived from iPSC lines were characterized as previ-
ously described (Lian et al., 2010). In the current study, two BM-
MSCs cell lines and two iPSC-MSCs (Lee NL-iPSC-MSCs and
IMR90-iPSC-MSCs) were used. Primary NMCs were obtained andcultured. HL-1 cells, adult mice CM cell line, and adult human
ventricular CM AC16 cells were cultured.Animal Model
All experiments with live animals were carried out in accordance
with relevant guidelines and regulations of the University of Hong
Kong and approved by the Committee on the Use of Live Animals
in Teaching and Research (CULTAR). A mouse model of AIC was
induced in adult mice (6–8 weeks, ICR strain) by intraperitoneal in-
jection of Dox (3 mg/kg, three times per week with a total cumula-
tive dose of Dox of 18 mg/kg) (Zhang et al., 2015). In the negative
control group, healthy mice were injected with the same volume
of PBS. Echocardiography was performed 1 week after the last Dox
injection to confirm the successful creation of an AIC model. Mice
with AIC were randomized to receive intramyocardial injection of
(1) PBS (Dox group, n = 16), (2) 3.0 3 105 BM-MSCs (BM-MSCs
group, n = 14), (3) 3.0 3 105 iPSC-MSCs (iPSC-MSCs group, n =
14), or (4) 3.0 3 105 iPSC-MSCs treated with TNFaIP2siRNA (iPSC-
MSCs-TNFaIP2si group, n = 12) at four sites in the left ventricle.
Three weeks after cell transplantation, hemodynamic measure-
ments were performed after the echocardiographic measurements.Statistical Analysis
Values are expressed as means ± SD. Significant differences be-
tween groups were analyzed by unpaired Student’s t test for two
groups or one-wayANOVA followed by the Bonferroni test formul-
tiple-group comparison. A p value <0.05 was considered statisti-
cally significant.
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